| Novaferon (recombinant anti-tumor and anti-virus protein) / Genova |
ChiCTR2000030000: An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19) |
|
|
| Recruiting | 4 | 50 | | Ganovo/ ritonavir oral ;Pegasys injection ;Novaferon intramuscular injection+Spray inhalation ;Coriolus oral ;TCM+Spray inhalation | Nanchang Ninth Hospital; Nanchang Ninth Hospital, Ascletis Pharmaceuticals CO., LTD. | Pneumonia caused by new coronavirus | | | | |
ChiCTR-TRC-10000982: Novaferon for chronic hepatitis B: a phase Ⅰrandomized open-label control trial |
|
|
| Completed | 4 | 40 | | Novaferon, 10ug intramuscular injection, once daily in the first day; Day 2 to day 7 not given the medication; followed injection 10ug a day, during week 2 to week 7 ;Novaferon, 10ug intramuscular injection, thrice weekly for week 1-6 ;Novaferon, 10ug intramuscular injection, once daily for the first week; followed by 20ug, thrice weekly for week 2-6 | Beijing YouAn Hospital, Capital Medical University; Genova Biotech Company, Ltd, Genova Biotech Company, Ltd. , National Novel Drug Development plan | Chronic Hepatitis B | | | | |
ChiCTR2000029573: A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection |
|
|
| Recruiting | 4 | 480 | China | antiviral therapy and Chinese medicine treatment ;antiviral therapy, Chinese medicine treatment, and Novaferon atomization ;antiviral therapy and Chinese medicine treatment ;antiviral therapy, Chinese medicine treatment, and Novaferon atomization | The First Affiliated Hospital of Medical College of Zhejiang University; The First Affiliated Hospital of Medical College of Zhejiang University, coordinater | novel coronavirus pneumonia | | | | |
ChiCTR2000029496: A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19) |
|
|
| Recruiting | 4 | 90 | | On the basis of routine medical treatment, the patients were given Novaferon Atomization inhalation, 20ug each time, twice a day, 7-14 days. ;On the basis of routine medical treatment, the patients were given lopinavir / ritonavir tablets (Kaletra) twice a day, twice each time, 7-14 days. ;On the basis of routine medical treatment, combined with Novafron and Kaletra, the usage and course of treatment are the same as above. | The First Hospital of Changsha; The Second Xiangya Hospital of Central South University; The First Hospital of Changsha, Self financing and application for scientific research funds | Novel Coronavirus Pneumonia (COVID-19) | | | | |
ChiCTR2100041835: Antiviral Therapy and Long-term Outcome of Chronic Hepatitis B Patients in China (CATLOB study): a National Multicenter, Prospective, Observational Real-World Study (Shan Dong Province) |
|
|
| Recruiting | 4 | 100 | | Treatment with Novaferon | Huashan Hospital of Fudan University; Qingdao Municipal Hospital, Self-paying from patients | chronic hepatitis B | | | | |
